Related Experiment Videos
[Once more a discussion of the RSV affair]
R J Roorda1, H Schreuder, W M Van Aalderen
1afd. Kinderlongziekten, Kinderkliniek Academisch Ziekenhuis en Rijks Universiteit Groningen.
Insights
Respiratory syncytial virus (RSV) causes severe respiratory infections in young children, leading to symptoms like wheezing and breathing difficulties. Early diagnosis and isolation are crucial, especially for high-risk infants.
Area of Science:
- Pediatrics
- Virology
- Infectious Diseases
Context:
- Respiratory syncytial virus (RSV) is a leading cause of respiratory infections in infants and young children, particularly during autumn and winter.
- RSV infections can lead to severe lower respiratory tract illness, with symptoms varying by age.
Purpose:
- To summarize the clinical presentation, diagnosis, management, and outcomes of respiratory syncytial virus infections in pediatric populations.
- To highlight risk factors for severe disease and potential therapeutic interventions.
Summary:
- RSV infection presents with age-dependent symptoms including dyspnea, wheezing, cyanosis, and apneas, potentially requiring mechanical ventilation.
- Diagnosis is typically made via direct immunofluorescence, and isolation precautions are essential to prevent nosocomial spread.
- While overall mortality is low, high-risk infants (e.g., preterm, congenital heart disease, immunodeficiency) face increased risk; ribavirin therapy may be considered despite limited evidence.
- Long-term sequelae include recurrent wheezing and dyspnea, possibly linked to IgE-mediated hypersensitivity and mechanisms similar to asthma.
Impact:
- Informs clinical practice regarding RSV diagnosis and management in vulnerable pediatric populations.
- Emphasizes the importance of infection control measures in healthcare settings.
- Underscores the need for further research into effective antiviral therapies and understanding long-term respiratory consequences of RSV infection.
Abstract:
During autumn- and winter epidemics respiratory syncytial (RS) virus accounts for the majority of respiratory infections in infants and young children. In case of an acute lower respiratory tract infection, RS virus can induce serious symptoms. These are age-dependent. The most important symptoms in babies and toddlers are dyspnea, wheezing, cyanosis and apneas. In the case of respiratory insufficiency or fatigue, as well as recurrent apneas, mechanical ventilation is required. Diagnosis can be made using a direct immunofluorescence technique with monoclonal antibodies. To control the risk of nosocomial RS virus infections, isolation precautions are necessary. The overall mortality is low (less than 1%), but may be strikingly higher in children at risk: babies less than one month of age, preterm babies, infants with congenital heart- or pre-existent respiratory diseases, and those with severe immunodeficiency syndromes. In these subgroups therapy with ribavirin (Virazole) may be beneficial, although until now there is no strong evidence for the effectiveness of this antiviral agent. The majority of the children will have recurrent symptoms of dyspnea and wheezing over the subsequent years following the RS virus infection. In acute lower respiratory RS virus infection, there may be IgE mediated hypersensitivity reactions to viral agents, with release of chemical mediators of airway obstruction. The pathophysiological mechanisms might be comparable to those in patients with asthma.